Ocugen, Inc. (OCGN) vs Surrozen, Inc. (SRZN)

Ocugen, Inc. and Surrozen, Inc. are both Biotechnology companies. Ocugen, Inc. and Surrozen, Inc. are of similar size ($294.7M and $275.9M). Ocugen, Inc. grew revenue faster over the last twelve months: −3.66% against −8.79%. Ocugen, Inc. has the higher net margin (−1,786.3% vs −2,887.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Ocugen, Inc. leads on 8 and Surrozen, Inc. on 6.

Valuation

Metric OCGN SRZN Biotechnology median
P/E n/m n/m 8.50
P/S 57.68 23.78 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 36.22 14.92 9.21
Earnings yield (33.33%) (159.31%) (33.15%)
Free cash flow yield (23.10%) (12.78%) (25.50%)

Profitability

Metric OCGN SRZN Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (1,504.43%) (385.28%) 0.00%
Net margin (1,786.27%) (2,887.07%) 0.00%
Free cash flow margin (1,332.36%) (303.92%) 0.00%
Return on equity 1,211.66% 387.44% (56.36%)
Return on assets (92.03%) (304.47%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric OCGN SRZN Biotechnology median
Revenue growth (TTM) (3.66%) (8.79%) 6.02%
EPS growth (last fiscal year) (15.00%) (49.38%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OCGN SRZN Biotechnology median
Debt to equity (0.11) 0.00 0.00
Current ratio 0.80 12.14 4.72
Net debt to EBITDA (0.17) 2.15 0.96

Dividend

Metric OCGN SRZN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric OCGN SRZN Biotechnology median
Market cap 275.93m 294.66m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack